- Innoviva to Present at Morgan Stanley Global Healthcare Conference and Rodman & Renshaw 19th Annual Global Investment Conference
- GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort® Turbohaler® in COPD at ERS International Congress
- Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress
- Innoviva to Present at Wells Fargo and Baird Healthcare Conferences in Early September
- Innoviva Reports Second Quarter 2016 Financial Results
- Innoviva to Report Second Quarter 2016 Financial Results on July 28 at 5:00 p.m. EDT
Innoviva Inc (INVA:NSQ) closed at 10.84, -23.39% below its 52-week high of 14.15, set on Apr 20, 2016.
6.36Sep 29 201514.15Apr 20 2016
Markit short selling activity
|Market cap||1.25bn USD|
|EPS (TTM)||0.1543 USD|
|Annual div (IAD)||--|
|Annual div yield (IAD)||--|
|Div ex-date||Sep 08 2015|
|Div pay-date||Sep 30 2015|
Data delayed at least 15 minutes, as of Sep 29 2016 21:00 BST.